Skip to content

Interesting study that definitely needs follow-up to see if it also applies to women. Nice news for coffee drinkers - that coffee consumption may have protective effects against gum disease. From Medical Xpress:

Coffee drinkers—your gums may thank you

Coffee contains antioxidants. Antioxidants fight gum disease. Does coffee, then, help fight gum disease?  Lead author and 2014 DMD graduate Nathan Ng said, "We found that coffee consumption did not have an adverse effect on periodontal health, and, instead, may have protective effects against periodontal disease."

Coffee consumption was associated with a small but statistically significant reduction in number of teeth with periodontal bone loss. Researchers concluded that coffee consumption may be protective against periodontal bone loss in adult males—the group examined in the study.

Several more articles on the benefits of exercise. From Science Daily:

Train your heart to protect your mind

Exercising to improve our cardiovascular strength may protect us from cognitive impairment as we age, according to a new study. "Our body's arteries stiffen with age, and the vessel hardening is believed to begin in the aorta, the main vessel coming out of the heart, before reaching the brain. Indeed, the hardening may contribute to cognitive changes that occur during a similar time frame," explained the first author of the study. "We found that older adults whose aortas were in a better condition and who had greater aerobic fitness performed better on a cognitive test. We therefore think that the preservation of vessel elasticity may be one of the mechanisms that enables exercise to slow cognitive aging."

The researchers worked with 31 young people between the ages of 18 and 30 and 54 older participants aged between 55 and 75. This enabled the team to compare the older participants within their peer group and against the younger group who obviously have not begun the aging processes in question. None of the participants had physical or mental health issues that might influence the study outcome.

The results demonstrated age-related declines in executive function, aortic elasticity and cardiorespiratory fitness, a link between vascular health and brain function, and a positive association between aerobic fitness and brain function. "Although the impact of fitness on cerebral vasculature may however involve other, more complex mechanisms, overall these results support the hypothesis that lifestyle helps maintain the elasticity of arteries, thereby preventing downstream cerebrovascular damage and resulting in preserved cognitive abilities in later life."

From Science Daily:

Physically fit kids have beefier brain white matter than their less-fit peers

A new study of 9- and 10-year-olds finds that those who are more aerobically fit have more fibrous and compact white-matter tracts in the brain than their peers who are less fit. 'White matter' describes the bundles of axons that carry nerve signals from one brain region to another. More compact white matter is associated with faster and more efficient nerve activity.

The analysis revealed significant fitness-related differences in the integrity of several white-matter tracts in the brain: the corpus callosum, which connects the brain's left and right hemispheres; the superior longitudinal fasciculus, a pair of structures that connect the frontal and parietal lobes; and the superior corona radiata, which connect the cerebral cortex to the brain stem."All of these tracts have been found to play a role in attention and memory," Chaddock-Heyman said. 

From Science Daily:

Exercise may protect older women from irregular heartbeat

Increasing the amount or intensity of physical activity can cut the chances of older women developing a life-threatening irregular heartbeat, according to new research. Researchers found that post-menopausal women who were the most physically active had a 10 percent lower risk of developing atrial fibrillation (AF), compared to women with low levels of physical activity, even if they were obese. Obesity is an important risk factor for atrial fibrillation.

Reading this article, I kept thinking of vampires and Transylvania. But the million dollar question is - will it work? From New Scientist:

Young blood to be used in ultimate rejuvenation trial

 In October, people with Alzheimer's disease will be injected with the blood of young people in the hope that it will reverse some of the damage caused by the condition.

The scientists behind the experiment have evidence on their side. Work in animals has shown that a transfusion of young mouse blood can improve cognition and the health of several organs in older mice. It could even make those animals look younger. The ramifications for the cosmetics and pharmaceutical industries could be huge if the same thing happens in people.

Disregarding vampire legends, the idea of refreshing old blood with new harks back to the 1950s, when Clive McCay of Cornell University in Ithaca, New York, stitched together the circulatory systems of an old and young mouse – a technique called heterochronic parabiosis. He found that the cartilage of the old mice soon appeared younger than would be expected.

It wasn't until recently, however, that the mechanisms behind this experiment were more clearly understood. In 2005, Thomas Rando at Stanford University in California and his team found that young blood returned the liver and skeletal stem cells of old mice to a more youthful state during heterochronic parabiosis. The old mice were also able to repair injured muscles as well as young mice (Nature, doi.org/d4fkt5). Spooky things seemed to happen in the opposite direction, too: young mice that received old blood appeared to age prematurely. In some cases, injured muscles did not heal as fast as would be expected.

Several other experiments have shown similar effects. In 2012, Amy Wagers at Harvard University showed that young blood can reverse heart decline in old mice.

Once the researchers had ruled out the effect of reduced blood pressure on the older mice, they identified a protein in the blood plasma called growth differentiation factor 11 (GDF11) that appeared to fall with age. To see if it was linked to the rejuvenating effects, the team gave old mice with enlarged hearts daily injections of GDF11 for 30 days. Their hearts decreased in size almost as much as they had in the parabiosis experiments (Cell, doi.org/q2f).

In both mice and humans, GDF11 falls with age. We don't know why it declines, but we know it is involved in several mechanisms that control growth. It is also thought to mediate some age-related effects on the brain, in part by activation of another protein that is involved in neuronal growth and long-term memory.

So the billion-dollar question is: would a GDF11 boost have the same effect in humans? Wyss-Coray thinks it will, having taken the next step of injecting young human blood plasma into old mice. His preliminary results suggest that human blood has similar rejuvenating benefits for old mice as young mouse blood does.

"We saw these astounding effects," he says. "The human blood had beneficial effects on every organ we've studied so far."

Now, the final step – giving young human blood plasma to older people with a medical condition – is about to begin. Getting approval to perform the experiment in humans has been relatively simple, says Wyss-Coray, thanks to the long safety record of blood transfusions. So in early October, a team at Stanford School of Medicine will give a transfusion of blood plasma donated by people under 30 to older volunteers with mild to moderate Alzheimer's.

Following the impressive results in animal experiments, the team hopes to see immediate improvements in cognition, but Wyss-Coray cautions that it is still very experimental. All researchers involved in the work agree that GDF11 is unlikely to be the only factor that keeps organs youthful. "It's too optimistic to think there would be just one factor," says Francesco Loffredo, who studies the effects of young blood in old animals at Harvard University. "It's much more likely to be several factors that exert these effects in combination."

Alessandro Laviano at the Sapienza University of Rome in Italy says that the research on diseases of ageing certainly holds promise, but he is more interested in the potential use of young blood in chronic disease. ...Before moving to clinical trials in people with cancer we need to learn more about the dynamics of the beneficial factors in blood, says Laviano, such as when they are at their peak. Do we reach a peak at 5 or 35 years? "We just don't know," he says.

An earlier related exciting study (from May 2014) in which it was found that "the blood of young mice has the ability to restore mental capabilities in old mice". From Science Daily:

Infusion of young blood recharges brains of old mice

An interesting small study of the human armpit bacterial community. From Real Clear Science:

Antiperspirants Alter Your Armpit Bacteria and Could Actually Make You Smell Worse

In modern society, antiperspirants are widely hailed as a godsend, dispelling the inconvenient odors wafting from armpits everywhere. But a new study casts doubts on their vaunted position. As it turns out, antiperspirants may actually make you smell worse in the long run.

For 90% of all Americans, slathering on deodorants and antiperspirants is a daily occurrence, a precautionary measure against foul odors and unsightly sweat stains. The odors arise when bacteria living in our armpits break down lipids and amino acids excreted in sweat into more smelly substances. Deodorants employ antimicrobial agents that kill off bacteria, as well as chemicals that replace noxious odors with pleasant aromas. Deodorants that double as antiperspirants, like Degree, Old Spice, and Dove, take the process one step further by physically plugging sweat glands with aluminum-based compounds.

While most of us might only concern ourselves with the dry, aromatic benefits of antiperspirants and deodorants, researchers at the Laboratory of Microbial Ecology and Technology at the University of Ghent in Belgium are more interested in the effects on bacteria. Billions of bacteria dwell in the "rain forests" under our arms, and the substances we don are mucking with their habitats!

To uncover how deodorants and antiperspirants affect armpit bacteria, Chris Callewaert, a Ph.D student specializing in microbial ecology, and a team of researchers recruited eight subjects for a task a great many people (and especially their friends) might deem unbearable: Six males and two females pledged not to use deodorant or antiperspirant for an entire month. Specifically, four subjects stopped using their deodorants and another four stopped using their antiperspirant deodorant. (Most antiperspirants are also deodorants. See image below for an example.) Another control subject who did not regularly use either was asked to use deodorant for a month. The duration was chosen because it takes approximately 28 days for a new layer of skin cells to form.

The researchers analyzed the diversity and abundance of subjects' armpit bacteria at various timepoints before they stopped using antiperspirant, during the period of abstaining from antiperspirant, and for a few weeks after resuming the use of antiperspirant. Switching hygiene habits plainly altered the armpit bacterial communities of every subject. Since no two armpits and their resident bacteria are identical, it was difficult to pinpoint precise changes brought about by deodorants or antiperspirants, but one clear trend did materialize: antiperspirants resulted in a clear increase of Actinobacteria.

You might not recognize the name of Actinobacteria, but chances are, you've smelled them. Dominated by Corynebacterium, they are the major instigators of noxious armpit odor. Other microbes that inhabit the armpit, like Firmicutes and Staphylococcus, don't produce odors as quickly, nor are those odors nearly as pungent.

Callewaert believes the aluminum compounds in antiperspirants may be to blame, killing off "good," less smelly bacteria and allowing "bad" bacteria to dominate. His study found that deodorants which lack these sweat-blocking antiperspirant compounds are actually linked to a slight decrease of stinky Actinobacteria.

Though antiperspirants and deodorants are widely used, they are only a temporary fix."The measures we utilize today do not take away the initial source: the odor causing bacteria," Callewaert told RealClearScience. "Deodorants only mask unpleasant odors. We can do better than that. The follow up of this research is finding better solutions."

And Callewaert is already working on one: "armpit bacterial transplantation"."We take away the bad bacteria from the armpit of somebody with a body odor, and replace it with the good bacteria of a relative who doesn't have a body odor," he explained."So far we have helped over 15 people. For most subjects it brings immediate improvements. Most of them on a permanent time scale, although there are also people who suffer again from a body odor after some months."

The bottom line is to read the ingredients list on products, and avoid all products labeled "antimicrobial" or "antibacterial" (because those are the ones typically containing triclosan and triclorocarban). Over 2000 products contain antibacterial compounds. I've even seen them in pillows, pillow protectors, mattress pads, dish racks, toys, and blankets! As we know from the latest microbiology research, we need to cultivate a healthy microbiome, and not throw it out of whack by continuously trying to kill off all bacteria. From The Atlantic:

It's Probably Best to Avoid Antibacterial Soaps

Antimicrobial chemicals are so ubiquitous that a recent study found them in pregnant mothers' urine and newborns' cord blood. Research shows that their risks may outweigh their benefits.

Antimicrobial chemicals, intended to kill bacteria and other microorganisms, are commonly found in not just soaps, but all kinds of products—toothpaste, cosmetics, and plastics among them. There is evidence that the chemicals aren’t always effective, and may even be harmful, and their ubiquity means people are often continually exposed to them. One such chemical, triclosan, has previously been found in many human bodily fluids. New research found traces of triclosan, triclocarban, and butyl paraben in the urine of pregnant women, and the cord blood of newborn infants. 

The research looked at the same population of 180 expectant mothers living in Brooklyn, New York, most of Puerto Rican descent. In a study published last week in Environmental Science and Technology, researchers from Arizona State University and State University of New York’s Downstate School of Public Health found triclosan in 100 percent of the women’s urine samples, and triclocarban in 87 percent of the samples. Of the 33 cord blood samples they looked at, 46 percent contained triclosan and 23 percent contained triclocarban.

In another, still-unpublished study, the researchers found that all of the cord blood samples contained “at least one paraben,” according to Dr. Rolf Halden, director of ASU’s Center for Environmental Security. 

Triclosan and triclocarban are endocrine disruptors, Halden explains. The risk there is that the chemicals can mimic thyroid hormones, potentially disrupting the metabolism and causing weight gain or weight loss. Previous research has also shown a connection between higher levels of triclosan in urine, and allergy diagnoses in children.

In the study looking at butyl paraben, the researchers found an association between higher exposure to the chemical, and a smaller head circumference and length of babies after they were born. Butyl paraben is used as a preservative, so it’s found in a wider breadth of products, according to Halden.

From Science News: Pregnant women, fetuses exposed to antibacterial compounds face potential health risks 


As the Food and Drug Administration mulls over whether to rein in the use of common antibacterial compounds that are causing growing concern among environmental health experts, scientists are reporting that many pregnant women and their fetuses are being exposed to these substances. The compounds are used in more than 2,000 everyday products marketed as antimicrobial, including toothpastes, soaps, detergents, carpets, paints, school supplies and toys, the researchers say.

The problem with this, explains Pycke, a research scientist at Arizona State University (ASU), is that there is a growing body of evidence showing that the compounds can lead to developmental and reproductive problems in animals and potentially in humans. Also, some research suggests that the additives could contribute to antibiotic resistance, a growing public health problem.

Although the human body is efficient at flushing out triclosan and triclocarban, a person's exposure to them can potentially be constant. "If you cut off the source of exposure, eventually triclosan and triclocarban would quickly be diluted out, but the truth is that we have universal use of these chemicals, and therefore also universal exposure," says Rolf Halden, Ph.D., the lead investigator of the study at ASU.

Here it is, a list of 17 cancers linked to being overweight or obese. From Science Daily:

Overweight and obesity linked to 10 common cancers, over 12,000 cases every year in UK

A higher body mass index (BMI) increases the risk of developing 10 of the most common cancers, the largest study of its kind on BMI and cancer, involving more than 5 million adults in the UK, shows. Each 5 kg/m² increase in BMI was clearly linked with higher risk of cancers of the uterus (62% increase), gallbladder (31%), kidney (25%), cervix (10%), thyroid (9%), and leukemia (9%). Higher BMI also increased the overall risk of liver, colon, ovarian, and breast cancers.

Using data from general practitioner records in the UK's Clinical Practice Research Datalink (CPRD), the researchers identified 5·24 million individuals aged 16 and older who were cancer-free and had been followed for an average of 7·5 years. The risk of developing 22 of the most common cancers, which represent 90% of the cancers diagnosed in the UK, was measured according to BMI after adjusting for individual factors such as age, sex, smoking status, and socioeconomic status. A total of 166 955 people developed one of the 22 cancers studied over the follow-up period. BMI was associated with 17 out of the 22 specific types of cancer examined.

Each 5 kg/m² increase in BMI was clearly linked with higher risk of cancers of the uterus (62% increase), gallbladder (31%), kidney (25%), cervix (10%), thyroid (9%), and leukemia (9%). Higher BMI also increased the overall risk of liver (19% increase), colon (10%), ovarian (9%), and breast cancers (5%), but the effects on these cancers varied by underlying BMI and by individual-level factors such as sex and menopausal status. Even within normal BMI ranges, higher BMI was associated with increased risk of some cancers.

There was some evidence that those with high BMI were at a slightly reduced risk of prostate cancer and premenopausal breast cancer. Based on the results, the researchers estimate that excess weight could account for 41% of uterine and 10% or more of gallbladder, kidney, liver, and colon cancers in the UK.

I've always recommended that people eat as many unprocessed foods as possible, and that one should always read the ingredient list when buying processed and prepared foods. The Center for Science in the Public Interest strongly urges that people avoid the following food ingredients: aspartame, food dyes, mycoprotein (Quorn), and partially hydrogenated oils (trans fat). The following article may be an eye opener for those who think that the FDA (Food and Drug Administration) carefully regulates what goes into our food. Link to the full article to read all the health concerns with mycoprotein (Quorn), Epigllocatechin-3-gallate (EGCG), and carageenan. From The Washington Post:

Food additives on the rise as FDA scrutiny wanes

The explosion of new food additives coupled with an easing of oversight requirements is allowing manufacturers to avoid the scrutiny of the Food and Drug Administration, which is responsible for ensuring the safety of chemicals streaming into the food supply.

And in hundreds of cases, the FDA doesn’t even know of the existence of new additives, which can include chemical preservatives, flavorings and thickening agents, records and interviews show. “We simply do not have the information to vouch for the safety of many of these chemicals,” said Michael Taylor, the FDA’s deputy commissioner for food.

The FDA has received thousands of consumer complaints about additives in recent years, saying certain substances seem to trigger asthmatic attacks, serious bouts of vomiting, intestinal-tract disorders and other health problems.

At a pace far faster than in previous years, companies are adding secret ingredients to everything from energy drinks to granola bars. But the more widespread concern among food-safety advocates and some federal regulators is the quickening trend of companies opting for an expedited certification process to a degree never intended when it was established 17 years ago to, in part, help businesses.

A voluntary certification system has nearly replaced one that relied on a more formal, time-consuming review — where the FDA, rather than companies, made the final determination on what is safe. The result is that consumers have little way of being certain that the food products they buy won’t harm them“We aren’t saying we have a public health crisis,” Taylor said. “But we do have questions about whether we can do what people expect of us.”

In the five decades since Congress gave the FDA responsibility for ensuring the safety of additives in the food supply, the number has spiked from 800 to more than 9,000, ranging from common substances such as salt to new green-tea extracts. This increase has been driven largely by demand from busy Americans, who get more than half their daily meals from processed foods, according to government and industry records. 

Within the past six months, top officials at the FDA and in the food industry have acknowledged that new steps must be taken to better account for the additives proliferating in the food supply. 

For new, novel ingredients — or when approved additives are used in new ways — the law says companies should seek formal FDA approval, which must be based on rigorous research proving the additive is safe. The agency uses the phrase “food additive,” in a narrow legal sense, to apply to substances that get this approval.

But many other additives are common food ingredients — vinegar is considered a classic example. The law allows manufacturers to certify, based on research, that such ingredients are already Generally Recognized as Safe, or GRASFor both types of additives, FDA scientists initially conducted detailed reviews of the company’s research. The agency also published its own evaluation of that research in the Federal Register.

This oversight system shifted dramatically in 1997. In response to a shortage of staff members and complaints from industry that the process was too cumbersome and did not improve food safety, the FDA proposed new rules. The agency told companies that were going the GRAS route — which turned a years-long process into one of months — that they no longer would have to submit their research and raw data. The companies can share just a summary of their findings with the agency.

The changes didn’t work out as planned. For starters, most additives continued to debut without the FDA being notified. Moreover, companies that did choose to go through the FDA oversight process largely abandoned the formal approval route, opting instead for the new, cursory GRAS process, even for additives that could be considered new and novel, according to agency documents and an analysis of those records by the Natural Resources Defense Council.

An average of only two additive petitions seeking formal approval are filed annually by food and chemical companies, while the agency receives dozens of GRAS notifications, according to an NRDC analysis of FDA data. Hundreds of other food chemicals and ingredients have been introduced without notifying the FDA at all, according to agency officials, trade journals and food safety groups.

Companies often bypass the FDA altogether. Under the rules, companies may make their own GRAS determination. Sharing it with the agency and getting it to sign off is voluntary. This is the opposite of what the overisght law intended, the FDA’s Taylor said. 

Even when the FDA approves a new additive or signs off on a company’s GRAS determination, a safe ingredient can turn dangerous if its use becomes more widespread than the agency envisioned. And under the rules, the agency has little way of monitoring this threat after the initial introduction of the additive, called “post-market.”

During the initial review, the FDA sets limits for how much of a chemical or ingredient can be used in a particular product. But the cumulative consumption can soar as the additive is used in more and more types of food and beverages.

Even though you may want to avoid phthalates, it is very hard to avoid them because they are commonly found in plastic food and beverage containers, perfume, hair spray, deodorants, almost anything fragranced (shampoo, air fresheners,etc.), insect repellent, carpeting, vinyl flooring, plastic toys, the steering wheel in cars, soft tubing in medical devices, etc. From Science Daily:

Reduced testosterone tied to endocrine-disrupting chemical exposure

Men, women and children exposed to high levels of phthalates -- endocrine-disrupting chemicals found in plastics and some personal care products -– tended to have reduced levels of testosterone in their blood compared to those with lower chemical exposure, according to a new study.

Testosterone is the main sex hormone in men. It contributes to a variety of functions in both sexes, including physical growth and strength, brain function, bone density and cardiovascular health. In the last 50 years, research has identified a trend of declining testosterone in men and a rise in related health conditions, including reduced semen quality in men and genital malformations in newborn boys.

Animal and cellular studies have found that some phthalates block the effects of testosterone on the body's organs and tissues. Researchers set out to examine whether these chemicals, which are widely used in flexible PVC plastics and personal care products, had a similar effect in humans.

"We found evidence reduced levels of circulating testosterone were associated with increased phthalate exposure in several key populations, including boys ages 6-12, and men and women ages 40-60," said one of the study's authors, John D. Meeker, MS, ScD, of the University of Michigan School of Public Health in Ann Arbor, MI. "This may have important public health implications, since low testosterone levels in young boys can negatively impact reproductive development, and in middle age can impair sexual function, libido, energy, cognitive function and bone health in men and women."

The cross-sectional study examined phthalate exposure and testosterone levels in 2,208 people who participated in the U.S. National Health and Nutrition Examination Survey, 2011-2012. Researchers analyzed urine samples to measure concentrations of 13 substances left after the body metabolizes phthalates. Each participant's testosterone level was measured using a blood sample.

Researchers found an inverse relationship between phthalate exposure and testosterone levels at various life stages. In women ages 40-60, for example, increased phthalate concentrations were associated with a 10.8 to 24 percent decline in testosterone levels. Among boys ages 6-12, increased concentrations of metabolites of a phthalate called di-(2-ethylhexyl) phthalate, or DEHP, was linked to a 24 to 34.1 percent drop in testosterone levels.

Treating tumors with bacteria is very exciting and new.From Medical Express:

Injected bacteria shrink tumors in rats, dogs and humans

A modified version of the Clostridium novyi (C. noyvi-NT) bacterium can produce a strong and precisely targeted anti-tumor response in rats, dogs and now humans, according to a new report from Johns Hopkins Kimmel Cancer Center researchers.

In its natural form, C. novyi is found in the soil and, in certain cases, can cause tissue-damaging infection in cattle, sheep and humans. The microbe thrives only in oxygen-poor environments, which makes it a targeted means of destroying oxygen-starved cells in tumors that are difficult to treat with chemotherapy and radiation. The Johns Hopkins team removed one of the bacteria's toxin-producing genes to make it safer for therapeutic use.

For the study, the researchers tested direct-tumor injection of the C. noyvi-NT spores in 16 pet dogs that were being treated for naturally occurring tumors. Six of the dogs had an anti-tumor response 21 days after their first treatment. Three of the six showed complete eradication of their tumors, and the length of the longest diameter of the tumor shrunk by at least 30 percent in the three other dogs.

In a Phase I clinical trial of C. noyvi-NT spores conducted at MD Anderson Cancer Center, a patient with an advanced soft tissue tumor in the abdomen received the spore injection directly into a metastatic tumor in her arm. The treatment significantly reduced the tumor in and around the bone. "She had a very vigorous inflammatory response and abscess formation," according to Nicholas Roberts, Vet.M.B., Ph.D. "But at the moment, we haven't treated enough people to be sure if the spectrum of responses that we see in dogs will truly recapitulate what we see in people."

"One advantage of using bacteria to treat cancer is that you can modify these bacteria relatively easily, to equip them with other therapeutic agents, or make them less toxic as we have done here, " said Shibin Zhou, M.D., Ph.D., associate professor of oncology at the Cancer Center.  He and colleagues at Johns Hopkins began exploring C. novyi's cancer-fighting potential more than a decade ago after studying hundred-year old accounts of an early immunotherapy called Coley toxins, which grew out of the observation that some cancer patients who contracted serious bacterial infections showed cancer remission.

The researchers focused on soft tissue tumors because "these tumors are often locally advanced, and they have spread into normal tissue," said Roberts, a Ludwig Center and Department of Pathology researcher. The bacteria cannot germinate in normal tissues and will only attack the oxygen-starved or hypoxic cells in the tumor and spare healthy tissue around the cancer.

Verena Staedtke, M.D., Ph.D., a Johns Hopkins neuro-oncology fellow, first tested the spore injection in rats with implanted brain tumors called gliomas. Microscopic evaluation of the tumors showed that the treatment killed tumor cells but spared healthy cells just a few micrometers away. The treatment also prolonged the rats' survival, with treated rats surviving an average of 33 days after the tumor was implanted, compared with an average of 18 days in rats that did not receive the C. noyvi-NT spore injection.

Zhou said that study of the C. noyvi-NT spore injection in humans is ongoing, but the final results of their treatment are not yet available. "We expect that some patients will have a stronger response than others, but that's true of other therapies as well. Now, we want to know how well the patients can tolerate this kind of therapy."

It may be possible to combine traditional treatments like chemotherapy with the C. noyvi-NT therapy, said Zhou, who added that the researchers have already studied these combinations in mice. "Another good thing about using bacteria as a therapeutic agent is that once they're infecting the tumor, they can induce a strong immune response against tumor cells themselves," Zhou said.

Two new studies find problems when vitamin D levels are low. From Science Daily:

Low vitamin D levels linked to increased risks after noncardiac surgery

Patients with low blood levels of vitamin D are at increased risk of death and serious complications after noncardiac surgery, suggests a study. The researchers analyzed the relationship between vitamin D level and surgical outcomes in approximately 3,500 patients who underwent operations other than heart surgery between 2005 and 2011. Only patients who had available data on vitamin D levels around the time of surgery -- from three months before to one month afterward -- were included in the study.

Most patients did not meet the recommended 25-hydroxyvitamin D concentration of greater than 30 nanograms per milliliter (ng/mL). The median vitamin D level was 23.5 ng/mL -- more than 60 percent of patients were in the range of vitamin D insufficiency (10 to 30 ng/mL). Nearly 20 percent had vitamin D deficiency (less than 10 ng/mL).

"Higher vitamin D concentrations were associated with decreased odds of in-hospital mortality/morbidity," the researchers write. For each 5 ng/mL increase in 25-hydroxyvitamin D level, the combined risk of death, cardiovascular events, or serious infections decreased by seven percent.

From Science Daily:

Vitamin D deficiency may reduce pregnancy rate in women undergoing IVF

Women with a vitamin D deficiency were nearly half as likely to conceive through in vitro fertilization (IVF) as women who had sufficient levels of the vitamin, according to a new study. Long known for its role in bone health, vitamin D is a steroid hormone that is emerging as a factor in fertility.

Women who had sufficient levels of vitamin D were nearly twice as likely to conceive as their counterparts with vitamin D deficiency. Since women with sufficient levels of the hormone were more likely to produce top-quality embryos, researchers theorized vitamin D was involved in the production of quality eggs in the ovaries as well as the successful implantation of embryos in the uterus.